PT925273E - Composicoes farmaceuticas contendo acidos 4-oxobutanoicos - Google Patents

Composicoes farmaceuticas contendo acidos 4-oxobutanoicos

Info

Publication number
PT925273E
PT925273E PT97936682T PT97936682T PT925273E PT 925273 E PT925273 E PT 925273E PT 97936682 T PT97936682 T PT 97936682T PT 97936682 T PT97936682 T PT 97936682T PT 925273 E PT925273 E PT 925273E
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
compositions containing
oxobutanoic acids
oxobutanoic
acids
Prior art date
Application number
PT97936682T
Other languages
English (en)
Inventor
Didier Mesangeau
Gerard Moinet
Lilian Doare
Micheline Kergoat
Philippe Maizeray
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT925273E publication Critical patent/PT925273E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
PT97936682T 1996-08-16 1997-08-05 Composicoes farmaceuticas contendo acidos 4-oxobutanoicos PT925273E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9610254A FR2752422B1 (fr) 1996-08-16 1996-08-16 Composition pharmaceutique contenant des acides 4-oxo-butanoiques

Publications (1)

Publication Number Publication Date
PT925273E true PT925273E (pt) 2002-04-29

Family

ID=9495089

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97936682T PT925273E (pt) 1996-08-16 1997-08-05 Composicoes farmaceuticas contendo acidos 4-oxobutanoicos

Country Status (30)

Country Link
US (1) US6143787A (pt)
EP (1) EP0925273B1 (pt)
JP (1) JP3105545B2 (pt)
KR (1) KR100488430B1 (pt)
CN (1) CN1082370C (pt)
AR (1) AR009251A1 (pt)
AT (1) ATE208364T1 (pt)
AU (1) AU725440B2 (pt)
BR (1) BR9711315A (pt)
CA (1) CA2263348C (pt)
CY (1) CY2298B1 (pt)
CZ (1) CZ294165B6 (pt)
DE (1) DE69708130T2 (pt)
DK (1) DK0925273T3 (pt)
ES (1) ES2166098T3 (pt)
FR (1) FR2752422B1 (pt)
HK (1) HK1021728A1 (pt)
HU (1) HUP0004223A3 (pt)
ID (1) ID17875A (pt)
NO (1) NO312290B1 (pt)
PL (1) PL187371B1 (pt)
PT (1) PT925273E (pt)
RU (1) RU2175966C2 (pt)
SI (1) SI0925273T1 (pt)
SK (1) SK283055B6 (pt)
TR (1) TR199900329T2 (pt)
TW (1) TW438764B (pt)
UA (1) UA57031C2 (pt)
WO (1) WO1998007681A1 (pt)
ZA (1) ZA977327B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04318852A (ja) * 1991-04-18 1992-11-10 Fujitsu Ltd レジスト・パターン形成方法
CN100344616C (zh) 2001-06-12 2007-10-24 维尔斯达医疗公司 用于治疗代谢失调的化合物
FR2832633B1 (fr) * 2001-11-28 2004-09-24 Lipha Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR2832925B1 (fr) * 2001-12-03 2006-07-14 Lipha Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation
FR2834214B1 (fr) * 2001-12-28 2004-09-24 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR2834640B1 (fr) * 2002-01-11 2004-09-24 Lipha Composition pharmaceutique comprenant une glitazone et un acide 4-oxobutanoique et son utilisation pour traiter le diabete
EP1556085A4 (en) * 2002-11-01 2012-08-22 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
EP1575575B1 (en) * 2002-11-08 2010-05-19 High Point Pharmaceuticals, LLC Safe chemical uncouplers for the treatment of obesity
FR2849599B1 (fr) * 2003-01-07 2006-12-29 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete
FR2849598B1 (fr) * 2003-01-07 2006-09-22 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans
CN101912380A (zh) * 2003-04-15 2010-12-15 维尔斯达医疗公司 用于治疗代谢紊乱的化合物
WO2009071161A1 (en) 2007-12-03 2009-06-11 Merck Patent Gmbh Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK523288A (da) * 1987-10-06 1989-04-07 Hoffmann La Roche Aminosyrederivater
US5250517A (en) * 1987-10-06 1993-10-05 Hoffmann-La Roche Inc. Renin inhibiting compounds
CA1329680C (en) * 1987-11-23 1994-05-17 Harold Norris Weller, Iii N-heterocyclic alcohol derivatives
US5055466A (en) * 1987-11-23 1991-10-08 E. R. Squibb & Sons, Inc. N-morpholino derivatives and their use as anti-hypertensive agents

Also Published As

Publication number Publication date
KR20000068106A (ko) 2000-11-25
HK1021728A1 (en) 2000-06-30
FR2752422A1 (fr) 1998-02-20
ATE208364T1 (de) 2001-11-15
CN1227538A (zh) 1999-09-01
EP0925273A1 (fr) 1999-06-30
BR9711315A (pt) 1999-08-17
US6143787A (en) 2000-11-07
RU2175966C2 (ru) 2001-11-20
ES2166098T3 (es) 2002-04-01
ID17875A (id) 1998-02-05
HUP0004223A2 (hu) 2001-04-28
CN1082370C (zh) 2002-04-10
SI0925273T1 (en) 2002-04-30
DE69708130T2 (de) 2002-06-20
KR100488430B1 (ko) 2005-05-10
CZ49899A3 (cs) 1999-05-12
SK283055B6 (sk) 2003-02-04
EP0925273B1 (fr) 2001-11-07
SK18099A3 (en) 2000-03-13
ZA977327B (en) 1998-03-30
FR2752422B1 (fr) 1998-11-06
CA2263348C (en) 2008-05-13
NO312290B1 (no) 2002-04-22
JP2000506543A (ja) 2000-05-30
NO990707D0 (no) 1999-02-15
UA57031C2 (uk) 2003-06-16
PL331645A1 (en) 1999-08-02
PL187371B1 (pl) 2004-06-30
WO1998007681A1 (fr) 1998-02-26
CZ294165B6 (cs) 2004-10-13
TW438764B (en) 2001-06-07
AU3942297A (en) 1998-03-06
TR199900329T2 (xx) 1999-04-21
DE69708130D1 (de) 2001-12-13
AU725440B2 (en) 2000-10-12
AR009251A1 (es) 2000-04-12
DK0925273T3 (da) 2002-02-18
JP3105545B2 (ja) 2000-11-06
HUP0004223A3 (en) 2001-12-28
NO990707L (no) 1999-02-15
CY2298B1 (en) 2003-07-04
CA2263348A1 (fr) 1998-02-26

Similar Documents

Publication Publication Date Title
IS4706A (is) Lyfjasamsetningar
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
ID18352A (id) Komposisi-komposisi farmasi
DK0936913T3 (da) Oralt farmaceutisk præparat indeholdende ibandronat
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
PT925273E (pt) Composicoes farmaceuticas contendo acidos 4-oxobutanoicos
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
ID16781A (id) Formulasi-formulasi farmasi
EE03857B1 (et) Ravimkoostised külmkuivatamiseks
IS2515B (is) Lyfjasamsetningar
BR9507768A (pt) Composição farmacêutica
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
ITMI941169A0 (it) Formulazioni farmaceutiche
PT941100E (pt) Composicoes farmaceuticas
EE200000330A (et) Farmatseutilised kompositsioonid
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
ITMI950961A0 (it) Composizioni farmaceutiche contenenti gemfibrozil
FI952377A0 (fi) Farmaseuttisia ibuprofeenikoostumuksia
ITMI962628A0 (it) Composizione farmaceutica
FI962738A (fi) Farmaseuttiset koostumukset
NO994436D0 (no) Farmasöytiske sammensetninger
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
IT1284509B1 (it) Composizioni farmaceutiche effervescenti contenenti metansolfoanilidi
IT1288113B1 (it) Composizioni farmaceutiche effervescenti contenenti sobrerolo
SE9601854D0 (sv) Farmaceutisk komposition